Broadfin Capital, LLC, 10% Owner at Aegerion Pharmaceuticals, Inc. (AEGR), bought 276,000 shares at $1.60 ($459K) on 2016-09-09, disclosed to the SEC on 2016-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 100,000 | $160K | 34.8% |
| 2 | $1.70 | 76,000 | $129K | 28.1% |
| 3 | $1.70 | 100,000 | $170K | 37.0% |
| Total | $1.66 avg | 276,000 | $459K | 100% |
| Filing → |
| BDSI | SELL | 2019-05-14 | $9.0M | — | Filing → |
| REPH | SELL | 2018-05-24 | $1.1M | — | Filing → |
| REPH | SELL | 2018-03-15 | $2.0M | — | Filing → |